Article Text

Download PDFPDF
Successful minocycline treatment for multidrug-resistant Mycoplasma genitalium proctitis
  1. Hassan Tarhini1,2,
  2. Racha Ibrahim2,
  3. Antoine Bachelard2,
  4. Bao Phung2,
  5. Stephane Lo3,4,
  6. Jade Ghosn2,4
  1. 1 Hôpital NOVO, Pontoise, France
  2. 2 Infectious Diseases, Hopital Bichat—Claude-Bernard, Paris, France
  3. 3 Bacteriology Department, Hopital Bichat—Claude-Bernard, Paris, France
  4. 4 INSERM, Paris, Île-de-France, France
  1. Correspondence to Dr Hassan Tarhini, Hôpital NOVO, Pontoise, France; hassan.tarhini{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Resistant strains of Mycoplasma genitalium (MG) emerged in Europe, yet guidelines still recommend azithromycin and moxifloxacin as first-line treatments.1 2

A 52-year-old HIV-negative MSM presented for anal burning with no lesion. He was treated with ceftriaxone and doxycycline. Neisseria gonorrhoeae, Chlamydia trachomatis and syphilis came back negative. …

View Full Text


  • Handling editor Anna Maria Geretti

  • Contributors HT, AB and BP were the treating physicians. SL was the bacteriologist. HT and RI wrote the manuscript. JG supervised the work. JG, SL, AB and BP edited the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer-reviewed.